Replication data for: Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020

The dataset was generated from members of randomly selected households from an existing population-based infectious disease surveillance (PBIDS) who participated in a serosurvey. The participated provided blood specimens between 27th November and 5th December 2020 after consenting. The specimens wer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Munywoki, Patrick K, Nasimiyu, Carolyne, Alando, Moshe Dayan, Otieno, Nancy, Ombok, Cynthia, Njoroge, Ruth, Kikwai, Gilbert, Odhiambo, Dennis, Osita, Mike Powel, Ouma. Alice, Oduor, Clifford, Juma, Bonventure, Ochieng, Caroline, Mutisya, Immaculate, Ngere, Isaac, Dawa, Jeanette, Osoro, Eric, Njenga, M Kariuki, Bigogo, Godfrey, Munyua, Peninah, Lo, Terrence, Hunsperger, Elizabeth, Herman-Roloff, Amy
Format:	Dataset
Sprache:	eng
Schlagworte:	COVID-19 Households IgM and IgG Kenya Kibera Medicine, Health and Life Sciences Population-based SARS-CoV-2 Serology Serosurvey urban informal settlement
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The dataset was generated from members of randomly selected households from an existing population-based infectious disease surveillance (PBIDS) who participated in a serosurvey. The participated provided blood specimens between 27th November and 5th December 2020 after consenting. The specimens were tested for antibodies to the SARS-CoV-2 spike protein using the Wantai SARS-CoV-2 two-step antigen sandwich enzyme immunoassay kit (Wantai Biological Pharmacy Enterprise Ltd, Beijing, China).
DOI:	10.7910/dvn/lwjh9n